Eli Lilly Corp. buy Guggenheim
Start price
03.12.25
/
50%
€894.70
Target price
03.12.26
-
Performance (%)
-3.27%
Price
10:14
€865.40
Summary
This prediction is currently active. With a performance of -3.27%, the BUY prediction for Eli Lilly Corp. by Guggenheim is down slightly. This prediction currently runs until 03.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Eli Lilly Corp. | -1.286% |
| iShares Core DAX® | 2.018% |
| iShares Nasdaq 100 | -0.476% |
| iShares Nikkei 225® | -0.675% |
| iShares S&P 500 | -0.163% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25